1,2,4-Triazolo[4,3-a]quinoxalin-1-one: A versatile tool for the synthesis of potent and selective adenosine receptor antagonists

Journal of Medicinal Chemistry

Volumn 43, Issue 6, 2000, Pages 1158-1164

  Colotta, Vittoria ^a   Catarzi, Daniela ^a   Varano, Flavia ^a   Cecchi, Lucia ^a   Filacchioni, Guido ^a   Martini, Claudia ^b   Trincavelli, Letizia ^b   Lucacchini, Antonio ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; QUINOXALINE DERIVATIVE;

ARTICLE; BINDING AFFINITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; RECEPTOR BINDING;

ANIMALS; BINDING, COMPETITIVE; CATTLE; CELL LINE; CEREBRAL CORTEX; CORPUS STRIATUM; HUMANS; QUINOXALINES; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034704809     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991096e     Document Type: Article

References (37)

1. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors - pharmacology, structure - activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
2. Von Lubitz, D. K. J. E.; Jacobson, K. A. Behavioral effects of adenosine receptor stimulation. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology; Bellardinelli, L., Pelleg, A., Eds.; Kluwer: Norwell, 1995; pp 489-498.
3. Collis, M. G.; Hourani, S. M. O. Adenosine receptor subtypes. Trends Pharmacol. Sci. 1993, 14, 360-366.
4. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
5. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 1993, 44, 524-532.
6. 3-adenosine receptors. Drug Dev. Res. 1994, 33, 51-59.
7. Müller, C. E.; Stein, B. Adenosine receptor antagonists: structures and potential therapeutic applications. Curr. Pharm. Des. 1996, 2, 501-530.
8. 1-adenosine receptor antagonists. Exp. Opin. Ther. Patents 1997, 7, 419-440.
9. Poulsen, S.-A.; Quinn, R. J. Adenosine receptors for future drugs. Bioorg. Med. Chem. 1998, 6, 619-641.
10. 1 receptor antagonist with potent diuretic activity. J. Med. Chem. 1999, 42, 779-783.
11. 1 antagonists. 2. Structure - activity relationships on diuretic activities and protective effects against acute renal failure. J. Med. Chem. 1992, 35, 3066-3075.
12. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci. 1997, 18, 338-344.
13. Beaven, M. A.; Ramkumar, V.; Ali, H. Adenosine-A(3) receptors in mast-cells. Trends Pharmacol. Sci. 1994, 15, 13-14.
14. 3 stimulation inhibits migration of human eosinophils. J. Leukoc. Biol. 1997, 62, 465-468.
15. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 1994, 263, 59-67.
16. 3 receptor antagonists and protection cerebral ischemic damage in gerbils. Soc. Neurosci. 1997, 23, Abstr. 745.16, 1924.
17. 2 adenosine receptor antagonist. Pharm. Pharmacol. Lett. 1992, 2, 74-76.
18. Colotta, V.; Cecchi, L.; Catarzi, D.; Melani, F.; Filacchioni, G.; Martini, C.; Tacchi, P.; Lucacchini, A. Novel adenosine receptor ligands: 1,3-disubstituted[1]benzopyrano[2,3-c]pyrazol-4-ones. Synthesis and structure - activity relationships. Recept. Channels 1993, 1, 111-119.
19. 2a adenosine binding activity. Eur. J. Med. Chem. 1995, 30, 133-139.
20. 2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c]pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4-ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines. J. Med. Chem. 1995, 38, 1330-1336.
21. 1 receptors. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 39-41.
22. Shawali, A. S.; Albar, H. A. Kinetics and mechanism of dehydrochlorination of N-aryl-C-ethoxycarbonylformohydrazidoyl chlorides. Can. J. Chem. 1986, 64, 871-875.
23. Colotta, V.; Catarzi, D.; Varano, F.; Cecchi, L.; Filacchioni, G.; Galli, A.; Costagli, C. Tricyclic heteroaromatic systems. 1,2,4-Triazolo[4,3-a]quinoxalines and 1,2,4-triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. Arch. Pharm. Pharm. Med. Chem. 1997, 330, 387-391.
24. 1 adenosine receptors purified from human brain membranes. Eur. J. Biochem. 1992, 206, 171-177.
25. Klotz, K. N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B. B.; Lohes, M. J. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schiedeberg's Arch. Pharmacol. 1998, 357, 1-9.
26. Camaioni, E.; Costanzi, S.; Vittori, S.; Volpini, R.; Klotz, K. N.; Cristalli, G. New substituted 9-alkylpurines as adenosine receptor ligands. Bioorg. Med. Chem. 1998, 6, 523-553.
27. 1 receptor. Nucleosides Nucleotides 1991, 10, 1039-1047.
28. Sarges, R.; Howard, H. R.; Browne, R. G.; Lebel, L. A.; Seymour, P. A.; Koe, B. K. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J. Med. Chem. 1990, 33, 2240-2254.
29. 3 receptor subtypes. J. Med. Chem. 1998, 41, 2835-2845.
30. 3 receptor subtype. J. Med. Chem. 1996, 39, 4142-4148.
31. 3 receptor. Drug. Dev. Res. 1998, 45, 182-189.
32. 3 adenosine receptors. J. Med. Chem. 1996, 39, 802-806.
33. 2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones. Farmaco 1998, 53, 189-196.
34. 3 adenosine receptors. Mol. Pharmacol. 1994, 45, 978-982.
35. Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
36. 50) of an enzyme reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
37. 3 adenosine receptors. Life Sci. 1998, 63, 81-87.